10 June 2025 · Patients with mitochondrial variants have an increased risk of deafness with amikacin, gentamicin, neomycin and tobramycin. Guidance on testing is provided.
16 May 2025 · Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
16 May 2025 · Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
29 April 2025 · Sertraline is the first-line option in people with coronary heart disease. Alternatives include fluoxetine, paroxetine and mirtazapine.
11 April 2025 · Breastfeeding need not be withheld after commonly used amidotrizoate, barium, gadolinium or iodinated contrast agents. Applies to full term and healthy infants.